Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint – Roche has recently announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the time patients live without their disease [...]

New review highlights Femara benefits in terms of reduction of the risk of distant relapse in women with hormone-sensitive breast cancer – A new review underlining the significance of distant metastases in breast cancer outcomes highlights the benefits of aromatase inhibitors in women with hormone-sensitive early breast cancer. Femara is more effective in the neoadjuvant [...]

Seroquel XR once-daily prolonged tablets for the treatment of schizophrenia – AstraZeneca announced last month the Irish launch of Seroquel XR (quetiapine fumarate) Prolonged-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients. Schizophrenia is a serious brain disorder with symptoms including distorted perceptions of reality, hallucinations and delusions, illogical thinking, and [...]

Nilotinib Is Highly Active and Safe in Chronic Myelogenous Leukaemia Patients with Imatinib-Resistance or Intolerance – New data demonstrated the efficacy and tolerability of Tasigna (nilotinib) in the treatment of Chronic myelogenous leukaemia (CML) patients with Imatinib-Resistance or Intolerance for whom there are few therapeutic options. CML is a myeloproliferative disorder resulting from a chromosomal [...]

Zevalin Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment – Bayer Schering Pharma AG has received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) recommending Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma in Europe. Consolidation therapy is a [...]